Neolys Pharma
- Biotech or pharma, therapeutic R&D
Neolys Pharma is a preclinical-stage biotech company developing a new class of small oral molecules called aminosteroid derivatives. Its lead candidate, RM-581, is well tolerated and in the final stages of early development. RM-581 has shown the ability to block tumor progression or even reduce tumor size in various types of cancers that are difficult to treat with conventional chemotherapy.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}